Cold Allergy And Sinus Tablet Global Market Report 2025
상품코드:1760507
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
감기, 알레르기 및 부비동염 정제 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 5.3%의 CAGR로 376억 9,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안의 성장은 대기 오염 수준 증가, 도시화 진행, 노인 인구 증가, 졸지 않는 제제에 대한 수요 증가, 호흡기질환 증가 등이 견인할 것으로 예상됩니다. 예측 기간 동안 예상되는 주요 동향으로는 자연 요법 및 허브 요법으로의 전환, 병용요법에 대한 선호도 증가, 개별화된 알레르기 치료, 비강 약물전달 시스템의 혁신, 소아 친화적 제제의 중요성 등을 들 수 있습니다.
알레르기 및 호흡기질환의 발생률 증가는 향후 몇 년 동안 감기, 알레르기 및 부비동염 정제 시장의 성장을 견인할 것으로 예상됩니다. 이러한 질환은 알레르겐에 대한 면역 체계의 반응을 동반하여 호흡기에 영향을 미치고 천식, 알레르기성 비염과 같은 질병을 유발합니다. 알레르기 및 호흡기질환의 급증은 면역 및 호흡기에 유해한 반응을 유발하는 알레르겐 및 공기 중 자극 물질에 대한 노출을 증가시키는 대기 오염의 증가와 관련이 있습니다. 감기, 알레르기 및 부비동염 정제는 효과적인 증상 완화를 제공함으로써 이러한 증상을 관리하고 감기, 부비동 감염 및 알레르기 반응으로 고통받는 사람들의 삶의 질을 향상시킬 수 있습니다. 예를 들어, 2023년 9월 스위스에 본부를 둔 정부 간 기구인 세계보건기구(WHO)는 만성 호흡기질환이 410만 명의 사망 원인으로 심혈관질환(1,790만 명 사망), 암(930만 명 사망), 당뇨병(200만 명 사망)에 이어 세 번째로 많은 사망을 유발하고 있다고 보고했습니다. 이처럼 호흡기질환과 알레르기 질환의 유병률 상승이 감기, 알레르기, 부비동염 정제 시장의 수요를 촉진하고 있습니다.
감기, 알레르기, 부비동염 정제 분야의 주요 기업들은 장기적인 증상 완화 및 사용자 편의성 향상을 위해 서방형 정제와 같은 첨단 제형에 투자하고 있습니다. 서방형 정제는 치료 효과를 지속시키기 위해 약물을 장시간에 걸쳐 서서히 방출하도록 설계되어 있습니다. 예를 들어, 2022년 7월 인도에 본사를 둔 제약회사 Dr. Reddy's Laboratories Ltd.는 미국에서 일반의약품(OTC) 버전인 Allegra-D 24 HR을 출시했습니다. 이 제제는 펙소페나딘 염산염 180mg과 슈도에페드린 염산염 240mg을 함유한 서방형 제제로 24시간 동안 부비동 압력, 코막힘, 재채기를 완화합니다. 이 제품은 계절성 알레르기성 비염 및 이와 유사한 증상과 관련된 증상을 관리하기 위한 비용 효율적이고 졸음을 유발하지 않는 선택지를 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 감기, 알레르기, 부비동염 정제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
최종 이용 산업 분석
세계의 감기, 알레르기, 부비동염 정제 시장 : 성장률 분석
세계의 감기, 알레르기, 부비동염 정제 시장 실적 : 규모와 성장, 2019-2024년
세계의 감기, 알레르기, 부비동염 정제 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 감기, 알레르기, 부비동염 정제 전체 시장(TAM)
제6장 시장 세분화
세계의 감기, 알레르기, 부비동염 정제 시장 : 제품 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
항히스타민제
코막힘 해소제
기침약
거담제
배합정
세계의 감기, 알레르기, 부비동염 정제 시장 : 처방 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
정제
캡슐
액체
발포정
분말
세계의 감기, 알레르기, 부비동염 정제 시장 : 소비자 연령층별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
아동(0-12세)
청소년(13-19세)
성인(20-64세)
노인(65세 이상)
세계의 감기, 알레르기, 부비동염 정제 시장 : 용도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
알레르기성 비염
감기
부비동염
기타
세계의 감기, 알레르기, 부비동염 정제 시장 : 유통 채널별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
약국
온라인 스토어
슈퍼마켓 또는 하이퍼마켓
기타
세계의 감기, 알레르기, 부비동염 정제 시장 : 항히스타민제 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
Loratadine
Cetirizine
Fexofenadine
Diphenhydramine
Chlorpheniramine
세계의 감기, 알레르기, 부비동염 정제 시장 : 코막힘 해소제 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
Pseudoephedrine
Phenylephrine
Oxymetazoline
세계의 감기, 알레르기, 부비동염 정제 시장 : 기침약 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
Dextromethorphan
Codeine
Benzonatate
세계의 감기, 알레르기, 부비동염 정제 시장 : 거담제 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
과이페네신
염화암모늄
세계의 감기, 알레르기, 부비동염 정제 시장 : 배합정 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
항히스타민제·코막힘 해소제 배합
항히스타민제·기침약 배합
다증상 감기·인플루엔자 정제
제7장 지역별·국가별 분석
세계의 감기, 알레르기, 부비동염 정제 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 감기, 알레르기, 부비동염 정제 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
감기, 알레르기, 부비동염 정제 시장 : 경쟁 구도
감기, 알레르기, 부비동염 정제 시장 : 기업 개요
Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
Bayer AG Overview, Products and Services, Strategy and Financial Analysis
Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Takeda Pharmaceutical Company Limited
GlaxoSmithKline plc
Reckitt Benckiser Group plc
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sandoz Group AG
Alcon Inc.
Sun Pharmaceutical Industries Ltd.
Perrigo Company plc
Dr. Reddy's Laboratories
Cipla Limited
Hikma Pharmaceuticals plc
Lupin Ltd.
Glenmark Pharmaceuticals Ltd.
LETI Pharma GmbH
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
감기, 알레르기, 부비동염 정제 시장 2029년 : 새로운 기회를 제공하는 국가
감기, 알레르기, 부비동염 정제 시장 2029년 : 새로운 기회를 제공하는 부문
감기, 알레르기, 부비동염 정제 시장 2029년 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Cold allergy and sinus tablets are over-the-counter or prescription medications formulated to relieve symptoms related to colds, allergies, and sinus conditions. These tablets typically combine antihistamines, decongestants, and pain relievers to reduce inflammation, congestion, and discomfort caused by these conditions.
The main types of cold allergy and sinus tablets include antihistamines, decongestants, cough suppressants, expectorants, and combination tablets. Antihistamines are medications that block or reduce the effects of histamines, chemicals released by the immune system during allergic reactions. These products are available in various formulations, including tablets, capsules, liquids, effervescent tablets, and powders. The consumer age groups vary from children (0-12 years) to teenagers (13-19 years), adults (20-64 years), and seniors (65 years and above). These products address multiple conditions, such as allergic rhinitis, the common cold, sinusitis, and more. Distribution occurs through several channels, including pharmacies, online stores, supermarkets or hypermarkets, and others.
The cold allergy and sinus tablet market research report is one of a series of new reports from The Business Research Company that provides cold allergy and sinus tablet market statistics, including the cold allergy and sinus tablet industry global market size, regional shares, competitors with the cold allergy and sinus tablet market share, detailed cold allergy and sinus tablet market segments, market trends, and opportunities, and any further data you may need to thrive in the cold allergy and sinus tablet industry. This cold allergy and sinus tablet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cold allergy and sinus tablet market size has grown strongly in recent years. It will grow from $29.00 billion in 2024 to $30.64 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth during the historic period can be attributed to the increasing prevalence of seasonal allergies, a rise in over-the-counter (OTC) medication sales, greater awareness of allergy symptoms, a rise in sinus infections, and improved healthcare access in developing countries.
The cold allergy and sinus tablet market size is expected to see strong growth in the next few years. It will grow to $37.69 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. Growth during the forecast period is expected to be driven by higher levels of air pollution, increased urbanization, a growing elderly population, rising demand for non-drowsy formulations, and an uptick in respiratory illnesses. Key trends anticipated for the forecast period include a shift toward natural and herbal remedies, a growing preference for combination therapies, personalized allergy treatments, innovations in nasal drug delivery systems, and an emphasis on pediatric-friendly formulations.
The increasing incidence of allergies and respiratory disorders is projected to drive growth in the cold allergy and sinus tablet market in the years ahead. These conditions involve immune system responses to allergens and affect the respiratory system, leading to illnesses such as asthma and allergic rhinitis. The surge in allergies and respiratory issues is largely linked to rising air pollution, which heightens exposure to allergens and airborne irritants that trigger adverse immune and respiratory reactions. Cold allergy and sinus tablets assist in managing these conditions by providing effective symptom relief, thereby enhancing the quality of life for individuals suffering from colds, sinus infections, and allergic reactions. For example, in September 2023, the World Health Organization, an intergovernmental agency based in Switzerland, reported that chronic respiratory diseases were responsible for 4.1 million deaths, ranking behind cardiovascular disease (17.9 million deaths) and cancer (9.3 million deaths), and ahead of diabetes (2.0 million deaths). Thus, the rising prevalence of respiratory and allergic conditions is fueling demand in the cold allergy and sinus tablet market.
Key players in the cold allergy and sinus tablet sector are investing in advanced drug formulations, such as extended-release tablets, to provide prolonged symptom relief and greater convenience for users. Extended-release tablets are designed to gradually deliver medication over an extended timeframe, ensuring sustained therapeutic effects. For instance, in July 2022, Dr. Reddy's Laboratories Ltd., a pharmaceutical firm based in India, launched an over-the-counter (OTC) store-brand version of Allegra-D 24 HR in the United States. This formulation combines 180 mg of Fexofenadine HCl with 240 mg of Pseudoephedrine HCl in an extended-release format, offering 24-hour relief from sinus pressure, nasal congestion, and sneezing. The product delivers a cost-effective, non-drowsy alternative for managing symptoms associated with seasonal allergic rhinitis and similar conditions.
In June 2022, Glenmark Pharmaceuticals Ltd., an India-based drug manufacturer, acquired approved generic versions of several OTC medications from Wockhardt Ltd. for an undisclosed sum. This move was intended to strengthen Glenmark's foothold in the U.S. OTC market by broadening its range of approved generic offerings, enhancing its market presence, and improving access for consumers. Wockhardt Ltd. is also based in India and produces a variety of cold, allergy, and sinus treatment products.
The increasing incidence of allergies and respiratory disorders is projected to drive growth in the cold allergy and sinus tablet market in the years ahead. These conditions involve immune system responses to allergens and affect the respiratory system, leading to illnesses such as asthma and allergic rhinitis. The surge in allergies and respiratory issues is largely linked to rising air pollution, which heightens exposure to allergens and airborne irritants that trigger adverse immune and respiratory reactions. Cold allergy and sinus tablets assist in managing these conditions by providing effective symptom relief, thereby enhancing the quality of life for individuals suffering from colds, sinus infections, and allergic reactions. For example, in September 2023, the World Health Organization, an intergovernmental agency based in Switzerland, reported that chronic respiratory diseases were responsible for 4.1 million deaths, ranking behind cardiovascular disease (17.9 million deaths) and cancer (9.3 million deaths), and ahead of diabetes (2.0 million deaths). Thus, the rising prevalence of respiratory and allergic conditions is fueling demand in the cold allergy and sinus tablet market.
Key players in the cold allergy and sinus tablet sector are investing in advanced drug formulations, such as extended-release tablets, to provide prolonged symptom relief and greater convenience for users. Extended-release tablets are designed to gradually deliver medication over an extended timeframe, ensuring sustained therapeutic effects. For instance, in July 2022, Dr. Reddy's Laboratories Ltd., a pharmaceutical firm based in India, launched an over-the-counter (OTC) store-brand version of Allegra-D 24 HR in the United States. This formulation combines 180 mg of Fexofenadine HCl with 240 mg of Pseudoephedrine HCl in an extended-release format, offering 24-hour relief from sinus pressure, nasal congestion, and sneezing. The product delivers a cost-effective, non-drowsy alternative for managing symptoms associated with seasonal allergic rhinitis and similar conditions.
In June 2022, Glenmark Pharmaceuticals Ltd., an India-based drug manufacturer, acquired approved generic versions of several OTC medications from Wockhardt Ltd. for an undisclosed sum. This move was intended to strengthen Glenmark's foothold in the U.S. OTC market by broadening its range of approved generic offerings, enhancing its market presence, and improving access for consumers. Wockhardt Ltd. is also based in India and produces a variety of cold, allergy, and sinus treatment products.
Major players in the cold allergy and sinus tablet market are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc. , Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz Group AG, Alcon Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories, Cipla Limited, Hikma Pharmaceuticals plc, Lupin Ltd., Glenmark Pharmaceuticals Ltd., LETI Pharma GmbH.
North America was the largest region in the cold allergy and sinus tablet market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cold allergy and sinus tablet report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cold allergy and sinus tablet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cold allergy and sinus tablet market consists of sales of allerhin cold tablet, sinarest tablet, and allergix cold care tablet. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cold Allergy And Sinus Tablet Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cold allergy and sinus tablet market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cold allergy and sinus tablet ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cold allergy and sinus tablet market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Cold Allergy And Sinus Tablet Market Characteristics
3. Cold Allergy And Sinus Tablet Market Trends And Strategies
4. Cold Allergy And Sinus Tablet Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Cold Allergy And Sinus Tablet Growth Analysis And Strategic Analysis Framework
5.1. Global Cold Allergy And Sinus Tablet PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cold Allergy And Sinus Tablet Market Growth Rate Analysis
5.4. Global Cold Allergy And Sinus Tablet Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cold Allergy And Sinus Tablet Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cold Allergy And Sinus Tablet Total Addressable Market (TAM)
6. Cold Allergy And Sinus Tablet Market Segmentation
6.1. Global Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antihistamines
Decongestants
Cough Suppressants
Expectorants
Combination Tablets
6.2. Global Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsules
Liquids
Effervescent Tablets
Powders
6.3. Global Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Children (0-12 years)
Teenagers (13-19 years)
Adults (20-64 years)
Seniors (65 years and above)
6.4. Global Cold Allergy And Sinus Tablet Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Allergic Rhinitis
Common Cold
Sinusitis
Other Respiratory Conditions
6.5. Global Cold Allergy And Sinus Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmacies
Online Stores
Supermarkets Or Hypermarkets
Other Distribution Channels
6.6. Global Cold Allergy And Sinus Tablet Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Loratadine
Cetirizine
Fexofenadine
Diphenhydramine
Chlorpheniramine
6.7. Global Cold Allergy And Sinus Tablet Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pseudoephedrine
Phenylephrine
Oxymetazoline
6.8. Global Cold Allergy And Sinus Tablet Market, Sub-Segmentation Of Cough Suppressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dextromethorphan
Codeine
Benzonatate
6.9. Global Cold Allergy And Sinus Tablet Market, Sub-Segmentation Of Expectorants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Guaifenesin
Ammonium Chloride
6.10. Global Cold Allergy And Sinus Tablet Market, Sub-Segmentation Of Combination Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antihistamine-Decongestant Combos
Antihistamine-Cough Suppressant Combos
Multi-Symptom Cold And Flu Tablets
7. Cold Allergy And Sinus Tablet Market Regional And Country Analysis
7.1. Global Cold Allergy And Sinus Tablet Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cold Allergy And Sinus Tablet Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cold Allergy And Sinus Tablet Market
8.1. Asia-Pacific Cold Allergy And Sinus Tablet Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cold Allergy And Sinus Tablet Market
9.1. China Cold Allergy And Sinus Tablet Market Overview
9.2. China Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cold Allergy And Sinus Tablet Market
10.1. India Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cold Allergy And Sinus Tablet Market
11.1. Japan Cold Allergy And Sinus Tablet Market Overview
11.2. Japan Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cold Allergy And Sinus Tablet Market
12.1. Australia Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cold Allergy And Sinus Tablet Market
13.1. Indonesia Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cold Allergy And Sinus Tablet Market
14.1. South Korea Cold Allergy And Sinus Tablet Market Overview
14.2. South Korea Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cold Allergy And Sinus Tablet Market
15.1. Western Europe Cold Allergy And Sinus Tablet Market Overview
15.2. Western Europe Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cold Allergy And Sinus Tablet Market
16.1. UK Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cold Allergy And Sinus Tablet Market
17.1. Germany Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cold Allergy And Sinus Tablet Market
18.1. France Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cold Allergy And Sinus Tablet Market
19.1. Italy Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cold Allergy And Sinus Tablet Market
20.1. Spain Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cold Allergy And Sinus Tablet Market
21.1. Eastern Europe Cold Allergy And Sinus Tablet Market Overview
21.2. Eastern Europe Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cold Allergy And Sinus Tablet Market
22.1. Russia Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cold Allergy And Sinus Tablet Market
23.1. North America Cold Allergy And Sinus Tablet Market Overview
23.2. North America Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cold Allergy And Sinus Tablet Market
24.1. USA Cold Allergy And Sinus Tablet Market Overview
24.2. USA Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cold Allergy And Sinus Tablet Market
25.1. Canada Cold Allergy And Sinus Tablet Market Overview
25.2. Canada Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cold Allergy And Sinus Tablet Market
26.1. South America Cold Allergy And Sinus Tablet Market Overview
26.2. South America Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cold Allergy And Sinus Tablet Market
27.1. Brazil Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cold Allergy And Sinus Tablet Market
28.1. Middle East Cold Allergy And Sinus Tablet Market Overview
28.2. Middle East Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cold Allergy And Sinus Tablet Market
29.1. Africa Cold Allergy And Sinus Tablet Market Overview
29.2. Africa Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cold Allergy And Sinus Tablet Market Competitive Landscape And Company Profiles
30.1. Cold Allergy And Sinus Tablet Market Competitive Landscape
30.2. Cold Allergy And Sinus Tablet Market Company Profiles
30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
31. Cold Allergy And Sinus Tablet Market Other Major And Innovative Companies
31.1. Takeda Pharmaceutical Company Limited
31.2. GlaxoSmithKline plc
31.3. Reckitt Benckiser Group plc
31.4. Teva Pharmaceutical Industries Ltd.
31.5. Mylan N.V.
31.6. Sandoz Group AG
31.7. Alcon Inc.
31.8. Sun Pharmaceutical Industries Ltd.
31.9. Perrigo Company plc
31.10. Dr. Reddy's Laboratories
31.11. Cipla Limited
31.12. Hikma Pharmaceuticals plc
31.13. Lupin Ltd.
31.14. Glenmark Pharmaceuticals Ltd.
31.15. LETI Pharma GmbH
32. Global Cold Allergy And Sinus Tablet Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cold Allergy And Sinus Tablet Market
34. Recent Developments In The Cold Allergy And Sinus Tablet Market
35. Cold Allergy And Sinus Tablet Market High Potential Countries, Segments and Strategies
35.1 Cold Allergy And Sinus Tablet Market In 2029 - Countries Offering Most New Opportunities
35.2 Cold Allergy And Sinus Tablet Market In 2029 - Segments Offering Most New Opportunities
35.3 Cold Allergy And Sinus Tablet Market In 2029 - Growth Strategies
